Xeris Biopharma Holdings, Inc. (XERS) Cash Flow Annual - Discounting Cash Flows
Xeris Biopharma Holdings, Inc.
XERS (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
Report Filing: 2025-05-08 2025-03-06 2024-03-06 2023-03-08 2022-03-11 2022-03-11 2020-12-31 2019-03-06 2017-12-31 2016-12-31
Net Income/Starting Line -45.08 -54.84 -62.26 -94.66 -94.66 -122.7 -91.14 -60.08 -26.55 -13.21
Cash From Operating Activities -26.71 -36.98 -47.02 -102.9 -102.9 -95.53 -80.56 -56.28 -24.66 -16.09
Depreciation and Amortization 12.11 12.62 13.16 12.67 12.67 1.88 1.47 0.32 0.177 0.116
Deferred Income Tax -2.58 -2.27 -1.25 -1.42 -1.42 1.11 0.536 -0.414 0 0
Stock Based Compensation 19.04 18.36 10.72 12.16 11.38 8.27 6.48 1.73 0.499 0.54
Other Non-Cash Items 13.3 -2.04 -1.1 3.52 3.52 0.961 3.1 0.56 0.094 0.049
Changes in Working Capital -4.08 -8.82 -6.29 -35.15 -35.15 11.85 -2.8 1.61 1.12 -3.58
Accounts Receivable -8.92 -1.22 -8.37 -13.37 -13.37 -6.24 -2.18 -1.67 -1.1 0.204
Inventory -6.93 -8.78 -14.8 -7.46 -7.46 -7.42 -5.14 4.04 1.7 -0.846
Accounts Payable -1.08 -9.61 6.96 -4.32 -4.32 5.53 -2.49 -1.11 0.661 -2.91
Deferred Revenue 13.57 10.79 9.92 -9.99 -9.99 19.98 7.01 0.345 -0.14 -0.032
Other Working Capital -0.723 0 0 0 0 0 0 0 0 0
Cash From Investing Activities 24.52 4.88 -6 34.46 34.46 97.96 -27.41 -68.26 -0.7 -0.035
Investments in Property Plant and Equipment -0.717 -0.868 -2.26 -0.524 -0.524 -1.08 -0.377 -1.51 -0.7 -0.035
Payments for Acquisitions 0 0 0 0 38.47 38.47 0.377 0 0 0
Purchases of Securities -10 -34.48 -43.74 0 -43.02 -43.02 -101.8 -68.85 0 0
Sales and Maturities of Investments 35.24 40.24 40 34.98 34.98 103.6 74.75 2.1 0 0
Other Investing Activities 5 0 0 34.98 4.55 -27.03 -0.377 -66.75 0 0
Cash From Financing Activities -2.16 36.17 -1.61 127.5 127.5 27.25 126.1 128.2 35.14 3.9
Debt Repayment 0 38.17 0 102.7 0 69.75 25 35 0 -0.032
Common Stock Issued 0 0 0 30 27 65.89 61.69 98.33 0.159 0.071
Common Stock Repurchased -8.3 -3.73 -1.01 -0.468 -0.534 -0.063 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 6.13 1.73 -0.604 -4.78 0.781 -9.51 55.53 4.11 35.14 3.94
Effect of Forex Changes on Cash 0 0 0 0 -0.003 -0.003 -0.022 0 0 0
Net Change in Cash 4.96 4.07 -54.64 59.04 59.04 29.67 18.08 3.67 9.78 -12.22
Cash at Beginning of Period 57.6 71.67 126.3 67.27 67.27 37.6 19.52 42.05 32.27 44.49
Cash at End of Period 62.56 75.74 71.67 126.3 126.3 67.27 37.6 45.72 42.05 32.27
Free Cash Flow -27.43 -37.85 -49.29 -103.4 -103.4 -96.62 -80.94 -57.79 -25.36 -16.12
Operating Cash Flow -26.71 -36.98 -47.02 -102.9 -102.9 -95.53 -80.56 -56.28 -24.66 -16.09
Capital Expenditure -0.717 -0.868 -2.26 -0.524 -0.524 -1.08 -0.377 -1.51 -0.7 -0.035
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us